Skip to content

Author

H. Rehman

We have 6 of 85 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Discovery of a Potential Inhibitor Against A42R Profilin-like Protein of Monkeypox Virus through In Silico High-throughput Screening

Monkeypox (Mpox) outbreak is a worldwide challenge, and recent reports are indicating its quick spread in certain regions, especially Africa, and new cases emerging in other countries. World Health Organization declared it as emergency concern for public health in 2024 due to a new clade epidemic in Africa. As of l...

Sidrah Akram, H. Rehman, S. Mehboob et al. · 0 citations
Open access Aug 2026

In-silico characterization of HspBP1 gene for identification of SNPs associated with silent estrus behavior in buffalo

Silent estrus behavior in buffalo is a great challenge to the sustainability of the dairy sector in Pakistan. To deal with reproductive failure, selection of animals with good estrus signs is crucial at the time of breeding. The current study analyzed the heat shock binding protein 1 ( HspBP1 ) to identify the sing...

Nadia Hussain, F. Muccee, H. Rehman et al. · 0 citations
Sep 2026

QSAR Modeling, In-silico ADMET, Molecular Docking, Biological Efficacy and Retrosynthesis: Study of Potential Anti-cancer Agents with Inhibitory Effect on Liver Cancer Stem Cells

Pr3 has a higher effectiveness in treating liver cancer when compared to the other compounds, emerges as a promising hit candidate for further experimental investigation and Lipinski characteristics and synthetic accessibility coefficient suggest their potential for therapeutic use.

Y. Moukhliss, Y. Koubi, L. Naanaai et al. · 0 citations
Aug 2026

Computational and Structure-Guided E-Pharmacophore-Based Virtual Screening for the Identification of Novel NEK2 Kinase Inhibitors as Potential Anticancer Agents

The overall results of the MD showed the overall stability of the NEK2–ligand complexes, and thus these three compounds are promising NEK2 inhibitor candidates and could be further validated in vitro and in vivo for clinical application.

H. Rehman, Ayesha Latif, Hafiz Muhammad Hammad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.